Hyep Ivan

Bicara Therapeutics Inc. Common Stock ยท Chief Financial Officer

Hyep Ivan is listed in public filings as officer: Chief Financial Officer. This Hyep Ivan insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Bicara Therapeutics Inc. Common Stock (BCAX). Investors use Hyep Ivan's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Bicara Therapeutics Inc. Common StockBCAX$3.0M145.4k sharesSellMay 21, 2026$187.9K9.2k shares$20.42--
Bicara Therapeutics Inc. Common StockBCAX$267k70.6k sharesGrant / ExerciseMay 21, 2026$34.9K9.2k shares$3.79--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Bicara Therapeutics Inc. Common StockBCAX$3.3M145.4k sharesSellApr 21, 2026$211.6K9.2k shares$23.00--
Bicara Therapeutics Inc. Common StockBCAX$151k39.7k sharesGrant / ExerciseApr 21, 2026$34.9K9.2k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.7M145.4k sharesSellMar 23, 2026$170.3K9.2k shares$18.52--
Bicara Therapeutics Inc. Common StockBCAX$185k48.9k sharesGrant / ExerciseMar 23, 2026$34.9K9.2k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.7M145.4k sharesSellMar 4, 2026$54.1K3k shares$18.25--
Bicara Therapeutics Inc. Common StockBCAX$302k79.8k sharesGrant / ExerciseMar 4, 2026$11.2K3k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.6M145.4k sharesSellMar 3, 2026$246.9K13.6k shares$18.22--
Bicara Therapeutics Inc. Common StockBCAX$220k58.1k sharesGrant / ExerciseMar 3, 2026$27.7K7.3k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$314k82.7k sharesGrant / ExerciseMar 3, 2026$23.6K6.2k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.1M125k sharesGrant / ExerciseFeb 2, 2026$2.1M125k shares$16.76--
Bicara Therapeutics Inc. Common StockBCAX$2.6M145.4k sharesSellJan 22, 2026$34.2K1.9k shares$18.15--
Bicara Therapeutics Inc. Common StockBCAX$248k65.5k sharesGrant / ExerciseJan 22, 2026$7.1K1.9k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.7M145.4k sharesSellDec 22, 2025$168.5K9.2k shares$18.31--
Bicara Therapeutics Inc. Common StockBCAX$337k89k sharesGrant / ExerciseDec 22, 2025$34.9K9.2k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.7M145.4k sharesSellNov 24, 2025$330.1K17.8k shares$18.55--
Bicara Therapeutics Inc. Common StockBCAX$372k98.2k sharesGrant / ExerciseNov 24, 2025$67.4K17.8k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$440k116k sharesGrant / ExerciseNov 21, 2025$2.3K605 shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.6M145.4k sharesSellNov 21, 2025$11.0K605 shares$18.15--
Bicara Therapeutics Inc. Common StockBCAX$2.6M145.4k sharesSellOct 9, 2025$116.9K6.4k shares$18.23--
Bicara Therapeutics Inc. Common StockBCAX$442k116.6k sharesGrant / ExerciseOct 9, 2025$24.3K6.4k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.6M145.4k sharesSellOct 8, 2025$102.5K5.6k shares$18.21--
Bicara Therapeutics Inc. Common StockBCAX$466k123k sharesGrant / ExerciseOct 8, 2025$21.3K5.6k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.6M145.4k sharesSellOct 7, 2025$332.4K18.2k shares$18.22--
Bicara Therapeutics Inc. Common StockBCAX$487k128.6k sharesGrant / ExerciseOct 7, 2025$69.1K18.2k shares$3.79--
Bicara Therapeutics Inc. Common StockBCAX$2.6M145.4k sharesSellOct 6, 2025$118.4K6.5k shares$18.17--
Bicara Therapeutics Inc. Common StockBCAX$557k146.9k sharesGrant / ExerciseOct 6, 2025$24.7K6.5k shares$3.79--